Sirtex wants medical professionals and patients to understand how SIR-Spheres® Y-90 resin microspheres can help improve clinical outcomes and the quality of life for people with liver cancer. To help achieve this objective, we want to provide medical journalists and health writers with balanced and comprehensive information about our company, our technology and the medical needs we address.


Latest News

01 Apr 2019
SIRT Approved for Routine Commissioning on the NHS
Read More
07 Mar 2019
Liver cancer: Selective Internal Radiation Therapy with SIR-Spheres® microspheres reimbursed in France
Read More
03 Jul 2017
New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
Read More
More News



Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×

This content is intended for journalists only

By clicking "Yes" you are confirming that you are a journalist. If you are not a journalist, then please click "Go to Homepage" which will direct you to the Sirtex homepage.

Yes Go to Homepage